Latest / DDReg Knowledge Capsule
Winning AIFA Drug Reimbursement in Italy: Regulatory & HTA Roadmap
Navigating pharmaceutical launch in Italy requires far more than securing European or national marketing authorization. In this episode of the DDReg Knowledge Capsule, we break down the critical regulatory and Health Technology Assessment (HTA) steps required by the Italian Medicines Agency (AIFA) to achieve pricing, reimbursement, and patient access.
For more info read our blog: https://resource.ddregpharma.com/blogs/italy-drug-approval-aifa-regulatory-steps/
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.